Skip to content

Comparison study of efficacy and safety of Laparoscopic Pectopexy and Sacropexy for POP treatment: a prospective, randomized clinical trial

Comparison study of efficacy and safety of Laparoscopic Pectopexy and Sacropexy for POP treatment: a prospective, randomized clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037209
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

experimental group:Laparoscopic Pectopexy
control group:Laparoscopic Sacropexy

Sponsors

Shanghai First Maternity and Infant hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary participation, good compliance, able to cooperate with experimental observation, and signed written informed consent; 2. pelvic prolapse patients with POP - Q stage III or above, who treated for the first time; 3. Patients with postoperative recurrence POP; 4. Ages 40 to 79 years; 5. No contraindications for operation.

Exclusion criteria

Exclusion criteria: 1. Poor general conditions; Patients with severe heart, liver, kidney and blood system diseases that cannot tolerate surgery; 2. Patients with poor compliance and lack of follow-up conditions; 3. Pregnant and lactating women; 4. Patients with fertility requirements.

Design outcomes

Primary

MeasureTime frame
POP/urinary incontinence sexual questionnaire 12 (PISQ-12);

Secondary

MeasureTime frame
gastrointestinal motility;pelvic floor distress inventory short form 20 (PFDI-20);pelvic floor impact questionnaire-short form 7 (PFIQ-7);pelvic organ prolapse quantification (POP-Q) scores;dynamic contrast-enhanced magnetic resonance imaging, DCE-MRI;Biomechanical analysis based on 3D-printing;Perioperative complications;

Countries

China

Contacts

Public ContactGuizhu Wu

Shanghai First Maternity and Infant Hospital

wugz6666@126.com+86 18930502615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026